DE-RESTRICT: Deimplementing Activity Restriction for Preterm Birth Prevention
Part of paid clinical trials in Philadelphia, Pennsylvania.
- Sponsor
- University of Pennsylvania
- Study ID
- NCT07698483
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Activity Restriction
- Bed Rest
- Low-Value Care
- Preterm Birth
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Multicomponent deimplementation strategy — BEHAVIORALA multicomponent strategy to reduce provider-recommended activity restriction and bedrest for preterm birth prevention, comprising development of a local clinical guideline aligned with national recommendations and identification of site champions; interactive educational sessions for providers with feedback; periodic audit and feedback to practices on the rate of activity restriction recommendations; and patient educational materials on safe physical activity in pregnancy that are made available to clinicians, who may choose to share them with patients. Delivered across the run-in, maintenance, and post-deimplementation periods and linked to the single study arm.
Study Details
DE-RESTRICT is a pilot study testing whether a strategy to reduce the use of activity restriction and bedrest in pregnancy is acceptable, appropriate, and feasible for prenatal care providers, and whether it changes how often activity restriction is recommended. Activity restriction and bedrest are commonly advised to try to prevent preterm birth, but they do not prevent it and may cause harm, and national guidelines recommend against them. The study takes place at two prenatal care settings within one health system and unfolds across four periods. In the pre-deimplementation period the study team develops a local clinical guideline and measures baseline outcomes. In the run-in period most provider education is delivered through interactive sessions with feedback, and audit and feedback begins. In the maintenance period audit and feedback continues. In the post-deimplementation period audit and feedback continues and outcomes are measured again. The study measures provider acceptability, appropriateness, and feasibility, the rate of activity restriction recommendations, patient-reported wellbeing and care experience, and the preterm birth rate.
Key Dates
- First listed
- Jul 13, 2026
- Start date
- Jul 1, 2026
- Status verified
- Jul 2026
- Primary completion
- Aug 31, 2027
- Completion
- Aug 31, 2027
Study Design
- Enrollment
- 237 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: Deimplementation strategyAll participating practices and providers receive the multicomponent deimplementation strategy. There is a single group and no control arm. The strategy comprises a locally developed clinical guideline aligning with national recommendations (developed in the pre-deimplementation period), interactive educational sessions with feedback delivered to providers (most delivered in the run-in period), and audit and feedback on the rate of activity restriction recommendations (delivered continuously from the run-in period through the post-deimplementation period).
Primary Outcome Measure
Acceptability of Intervention Measure (AIM) [ Time Frame: Post-deimplementation period (approximately months 13 to 14) ]
Central Contacts
- Beth Pineles, MD, PhD267-283-8210
- Kelli Jackson
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Hospital of the University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | Beth L Pineles, MD, PhD |
| Pennsylvania Hospital | Philadelphia | Pennsylvania | 19107 | Beth L Pineles, MD, PhD |
Find similar trials in Philadelphia, PA
Related Studies
- The Social Determinants of Health Screening and Referral ProjectEnrolling By Invitation · University of Massachusetts, Worcester · Denver, Colorado
- Daily Aspirin vs Split Dosing in High-risk Pregnancies (DASH)PHASE1/PHASE2 · Recruiting · Thomas Jefferson University · Philadelphia, Pennsylvania
- EVOLV-Rx VA: Evaluating Opportunities to Decrease Low-Value Prescribing in Community Living CentersNot Yet Recruiting · VA Office of Research and Development · Philadelphia, Pennsylvania
- Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGAPHASE4 · Recruiting · Woman's · Baton Rouge, Louisiana